Clinical Trial Pipeline

Parkinson’s Disease is a progressive neurological disorder that affects millions of individuals worldwide, leading to motor impairments, tremors, and difficulties in daily functioning. As research advances, innovative treatment approaches are being explored to improve the quality of life for those affected. One such groundbreaking initiative is our clinical trial, which aims to evaluate the safety and efficacy of the Sphere V3.0 Transcranial Electrical Stimulation (tES) system for Parkinson’s Disease.

This study offers participants the opportunity to undergo remote treatment sessions, ensuring convenience and accessibility. The devices used in this trial are provided to participants and closely monitored via telehealth technology, allowing researchers to assess their impact while maintaining patient comfort and safety. By leveraging cutting-edge neuromodulation techniques, we strive to enhance motor function and overall well-being for individuals battling Parkinson’s. Learn more by exploring our resources or reaching out for additional information. Your participation or support could contribute to advancements in Parkinson’s treatment and help shape the future of neurological care.